Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics
Go back to Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.88 -0.22 (3.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.10 | 52 Week High | $45.34 | |||
| Open | $6.12 | 52 Week Low | $15.92 | |||
| Day High | $6.12 | P/E | 2.52 | |||
| Day Low | $5.73 | EPS | $2.33 | |||
| Volume | 374,218 | |||||
